Takeda initiates development of Plasma-Derived Therapy for COVID-19

Japan based Takeda Pharmaceutical Company will share with members of the United States Congress that it is initiating th...

March 5, 2020 | Thursday | News
Saki Corporation opens new factory in Japan

Japan based Saki Corporation, an innovator in the field of automated optical and X-ray inspection equipment, announces t...

March 4, 2020 | Wednesday | News
Takeda to divest select assets to Hypera for $825M

Japan based Takeda Pharmaceutical Company Limited has announced that it has entered into an agreement to divest a p...

March 3, 2020 | Tuesday | News
UCB, Daiichi Sankyo to offer new treatment option for epilepsy

UCB Japan Co., Ltd, and Daiichi Sankyo Company, Limited are pleased to announce that a supplemental application for VIMP...

March 2, 2020 | Monday | News
Takeda acquires PvP Biologics focusing on celiac disease treatment

Japan based Takeda Pharmaceutical Company Limited announced that it has acquired US based PvP Biologics, Inc. follo...

February 28, 2020 | Friday | News
Eisai, FUJI YAKUHIN to work on hyperuricemia and gout treatment

Japan based Eisai Co., Ltd. and FUJI YAKUHIN CO., LTD.  have concluded a license agreement concerning dotinurad (ge...

February 27, 2020 | Thursday | News
Softbank leads $165 M funding for Karius

Japanese multinational conglomerate holding company SoftBank Group led the new funding round for US based firm...

February 26, 2020 | Wednesday | News
Eisai receives recognition for contribution towards liver diseases

Japan based pharmaceutical firm Eisai announced that it has received the President’s Award at the 8th Technology M...

February 25, 2020 | Tuesday | News
Eisai’s H3 Biomedicine appoints new CMO

H3 Biomedicine, Inc. (H3), precision medicine research & development subsidiary of Eisai Co has announced the a...

February 24, 2020 | Monday | News
BIO cancels Asia conference in Tokyo amid COVID-19 outbreak

The Biotechnology Innovation Organization (BIO) has announced, it is canceling the annual BIO Asia conference in Tokyo s...

February 24, 2020 | Monday | News
BitOne enhances remote medical services with 5G technology

Japan based BitOne Group Company Limited and IBO Telecom Company Limited, a Hong Kong-based subsidiary of IBO Techn...

February 19, 2020 | Wednesday | News
Chugai receives Orphan Drug Designation for RG6042

Japan based Chugai Pharmaceutical has announced that the Ministry of Health, Labour and Welfare (MHLW) has des...

February 18, 2020 | Tuesday | News
Researchers investigate cancer genomic landscape of Japan

Tokyo Medical and Dental University (TMDU), ACT Genomics (Taipei, Taiwan), and ACTmed (Japan) launched a joint clinical ...

February 17, 2020 | Monday | News
Japan explores muscular dystrophy associated cardiomyopathy

In a study recently published in Nature Communications, scientists at Japan based Okayama University describe ...

February 14, 2020 | Friday | News
Foundation Medicine & Chugai announce partnership with NCC

Foundation Medicine, Inc. and Chugai Pharmaceutical Co., Ltd. have entered into an agreement with the&nbs...

February 13, 2020 | Thursday | News
Nippon Shinyaku inks new agreement for prostate cancer treatment

Japan based Nippon Shinyaku Co., LTD. has announced that Janssen Pharmaceutical K.K. and Nippon Shinyaku entered into a ...

February 12, 2020 | Wednesday | News
Japan suggests combined drug treatment for lung cancer

Researchers at Japan based Kanazawa University report in the Journal of Thoracic Oncology a promising novel ap...

February 11, 2020 | Tuesday | News
Chugai collaborates with National Cancer Center

Japanese firm Chugai Pharmaceutical Co., Ltd. has announced that it has entered into an agreement with National Cancer C...

February 10, 2020 | Monday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls